ALQAEM International (FZE) and Biosign Technologies Inc. are Jointly Exhibiting at Arab Health 2011 in Dubai

SHARJAH, UAE, January 24, 2011 - ALQAEM International (FZE) ("Alqaem" or the "Company"), exclusive Biosign
master distributor for the Middle East and North Africa Region (M.E.N.A.)
today announced that they will be joining with Biosign Technologies Inc
(TSX-V:BIO), the Canadian manufacturer of the revolutionary UFIT(R)TEN-20
non-invasive glucometer, to exhibit at the 36th Annual Arab Health Exhibition
& Congress held in Dubai, UAE from January 24th to 27th, 2011 at Stand S1G61.

The Arab Health Exhibition & Congress is, by far, the largest healthcare
exhibition in the Middle East, and the second largest in the world. Arab
Health is viewed as a must-attend global event in the healthcare calendar.

John Rizvi, Managing Director of ALQAEM, stated: "Each year, over 66,000
professionals from 145 countries attend the Arab Health Exhibition. We are
excited to work directly with Biosign at such a prestigious event, and we
look forward to introducing the remarkable new UFIT(R)TEN-20 a non-invasive
glucometer to customers, resellers and medical professionals from the
M.E.N.A. region and all over the World. We anticipate an enthusiastic
response to the Biosign UFIT(R) non-invasive solution!"

UFIT(R) TEN-20 is an online medical device for self-monitoring of blood
pressure and blood glucose. The device takes the pulse at the wrist through
an inflatable cuff and immediately produces blood pressure and blood glucose
measurement results. All measurements are indirect, noninvasive, and passive.
The results are stored on Biosign servers along with the test sample.
Readings can be viewed by care providers on a secure web portal and/or
integrated into a patient's Electronic Health Record (EHR). The UFIT(R)
TEN-20 is approved under ISO 13485 for the non-invasive measurement of blood
pressure and blood glucose, and carries the CE Mark.

ALQAEM International (FZE) is a diversified trading and distribution
company headquartered in Sharjah Airport International Free Zone, United Arab
Emirates. A large potion of ALQAEM's business is health-care focused. Alqaem
directs healthcare sales teams in a number of Gulf countries. In July 2010
ALQAEM was appointed the exclusive Master Distributor for Biosign health
monitoring products for 10 countries in the M.E.N.A region. For more
information please go to www.alqaemhealthcare.com.

Biosign Technologies Inc. (TSX-V:BIO) provides biomedical and intelligent
systems for noninvasive monitoring of common health risks associated with
blood pressure, glucose and medication. Their core technology combines
measurement, analysis and rapid knowledge formation to support health
monitoring across global markets. The UFIT(R) medical device technology
powers quality data collection and analytics for clinical diagnostics,
self-care, wellness, disease state evaluation & management, and remote
patient monitoring. For more information on Biosign, please visit
www.biosign.com.

    Contact ALQAEM: Mr John Rizvi, Managing Director, Tel: +971-6-557-8661
    Email: info@alqaemhealthcare.com / Web: www.alqaemhealthcare.com

    Contact BIOSIGN investor relations:
    Mr. Alan S. Roemer, SVP
    The Trout Group LLC
    Phone: +1-646-378-2900
    Email : aroemer@troutgroup.com

Contact ALQAEM: Mr John Rizvi, Managing Director, Tel: +971-6-557-8661, Email: info at alqaemhealthcare.com / Web: www.alqaemhealthcare.com Contact BIOSIGN investor relations: Mr. Alan S. Roemer, SVP, The Trout Group LLC, Phone: +1-646-378-2900, Email : aroemer at troutgroup.com